Tivic Health Systems Inc. (TIVC)
0.33
-0.03 (-9.51%)
At close: Mar 03, 2025, 3:59 PM
0.32
-1.38%
After-hours: Mar 03, 2025, 07:59 PM EST
Company Description
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions.
Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation.
The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com.
Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.

Country | United States |
IPO Date | Nov 11, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 9 |
CEO | Jennifer Ernst |
Contact Details
Address: 25821 Industrial Boulevard Hayward, California United States | |
Website | https://www.tivichealth.com |
Stock Details
Ticker Symbol | TIVC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001787740 |
CUSIP Number | 888705100 |
ISIN Number | US8887052095 |
Employer ID | 81-4016391 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Jennifer Ernst | Co-Founder, Chief Executive Officer & Director |
Lisa G. Wolf | Interim Chief Financial Officer |
Michael Kevin Handley | President of Tivic Biopharma & Chief Operating Officer of Tivic Health |
Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 24, 2025 | 4 | Filing |
Feb 24, 2025 | 3 | Filing |
Feb 24, 2025 | 8-K | Current Report |
Feb 12, 2025 | 8-K | Current Report |
Feb 05, 2025 | 8-K | Current Report |
Jan 03, 2025 | DEF 14A | Filing |
Jan 03, 2025 | 8-K | Current Report |
Dec 23, 2024 | 8-K | Current Report |
Dec 23, 2024 | PRE 14A | Filing |
Dec 20, 2024 | 4 | Filing |